Literature DB >> 32873327

Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy).

Troels Thim1, Matthias Götberg2, Ole Fröbert3, Robin Nijveldt4, Niels van Royen4, Sergio Bravo Baptista5, Sasha Koul2, Thomas Kellerth3, Hans Erik Bøtker6, Christian Juhl Terkelsen6, Evald Høj Christiansen6, Lars Jakobsen6, Steen Dalby Kristensen6, Michael Maeng6.   

Abstract

OBJECTIVE: To evaluate agreement between instantaneous wave free ratio (iFR) and fractional flow reserve (FFR) for the functional assessment of nonculprit coronary stenoses at staged follow-up after ST-segment elevation myocardial infarction (STEMI).
RESULTS: We measured iFR and FFR at staged follow-up in 112 STEMI patients with 146 nonculprit stenoses. Median interval between STEMI and follow-up was 16 (interquartile range 5-32) days. Agreement between iFR and FFR was 77% < 5 days after STEMI and 86% after ≥ 5 days (p = 0.19). Among cases with disagreement, the proportion of cases with hemodynamically significant iFR and non-significant FFR were different when assessed < 5 days (5 in 8, 63%) versus ≥ 5 days (3 in 15, 20%) after STEMI (p = 0.04). Overall classification agreement between iFR and FFR was comparable to that observed in stable patients. Time interval between STEMI and follow-up evaluation may impact agreement between iFR and FFR.

Entities:  

Keywords:  FFR; Fractional flow reserve; Instantaneous wave-free ration; Nonculprit stenosis; ST-segment elevation myocardial infarction; iFR

Mesh:

Year:  2020        PMID: 32873327      PMCID: PMC7466494          DOI: 10.1186/s13104-020-05252-6

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

In patients with ST-segment elevation myocardial infarction (STEMI), nonculprit coronary stenoses may be identified [1]. Staged evaluation of these stenoses may rely on angiography alone, instantaneous wave free ratio (iFR), fractional flow reserve (FFR) or other invasive or noninvasive methods [2]. In stable patients, the agreement between iFR and FFR in determining hemodynamic significance is approximately 80% [3]. In patients with recent myocardial infarction, baseline coronary blood flow may be increased while maximal hyperaemic blood flow may be decreased in both culprit and nonculprit arteries [2, 4]. Increased baseline flow will tend to lower iFR values leading to overestimation of the hemodynamic significance of stenoses, while decreased maximal hyperaemic blood flow will tend to increase FFR values leading to underestimation of the hemodynamic significance of stenosis [2, 4]. Thereby, recent myocardial infarction may affect the agreement between iFR and FFR compared to stable conditions. In this iSTEMI (iFR in STEMI [5, 6]) substudy, we evaluated the agreement between iFR and FFR in nonculprit stenoses at staged follow-up after STEMI.

Main text

Methods

The iSTEMI study has been described [5, 6]. Briefly, we measured nonculprit stenosis iFR in the acute STEMI setting and nonculprit stenosis iFR and FFR at staged follow-up. Nonculprit stenosis FFR was not measured in the acute STEMI setting. In the current substudy, we examined agreement between nonculprit stenosis follow-up iFR and FFR < 5 days after STEMI (corresponding to follow-up during usual index admission duration) and after ≥ 5 days (corresponding to follow-up after usual index admission duration) after STEMI. In iSTEMI, time interval between STEMI and follow-up evaluation was at the discretion of the treating physicians. Patients were recruited at Aarhus University Hospital (Denmark), Skåne University Hospital (Sweden), Örebro University Hospital (Sweden), VU University Medical Center (The Netherlands), and Hospital Prof. Doutor Fernando Fonseca (Portugal). Intervals between STEMI and follow-up are presented as median (interquartile range). We considered iFR < 0.90 and FFR ≤ 0.80 hemodynamically significant. Proportions were compared using a proportion calculator (Stata/IC 13.1).

Results

The presented data are from 112 STEMI patients with completed follow-up iFR and FFR of 146 nonculprit stenoses [5]. We refer to the original publication for baseline patient data [5]. The median interval between STEMI and follow-up was 16 (5–32) days (Tables 1 and 2).
Table 1

Agreement between follow-up iFR and FFR of nonculprit lesions < 5 days after STEMI

iFR ≥ 0.90iFR < 0.90Total
FFR > 0.8011516
FFR ≤ 0.8031619
Total142135

iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, ST-segment elevation myocardial infarction. Follow-up interval: 2 (1–3) days

Table 2

Agreement between follow-up iFR and FFR of nonculprit lesions ≥ 5 days after STEMI

iFR ≥ 0.90iFR < 0.90Total
FFR > 0.8060363
FFR ≤ 0.80123648
Total7239111

iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, ST-segment elevation myocardial infarction. Follow-up interval: 28 (12–34) days

Agreement between follow-up iFR and FFR of nonculprit lesions < 5 days after STEMI iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, ST-segment elevation myocardial infarction. Follow-up interval: 2 (1–3) days Agreement between follow-up iFR and FFR of nonculprit lesions ≥ 5 days after STEMI iFR, instantaneous wave free ratio. FFR, fractional flow reserve. STEMI, ST-segment elevation myocardial infarction. Follow-up interval: 28 (12–34) days In patients re-evaluated < 5 days after STEMI, there was classification agreement between iFR and FFR in 77% of nonculprit stenoses. When staged evaluation was performed ≥ 5 days after STEMI, classification agreement was 86% (p = 0.19). Among cases with classification disagreement, the proportions of cases with hemodynamically significant iFR and non-significant FFR were different when assessed < 5 days (5 in 8, 63%) versus ≥ 5 days (3 in 15, 20%) after STEMI (p = 0.04). Individual values of follow-up iFR and FFR in patients with disagreement on nonculprit stenosis significance between iFR and FFR are presented in the Additional file 1.

Discussion

The time interval between myocardial infarction and normalisation of baseline coronary blood flow and maximal hyperaemic blood flow remains uncertain and may differ between patients. The impact of these temporary blood flow changes on iFR may resolve before the impact on FFR and the impact on iFR may need more than 2 weeks to resolve [4-8]. In the current study, the time interval between STEMI and nonculprit stenosis evaluation did not impact the overall agreement between iFR and FFR. However, among cases with disagreement between follow-up iFR and FFR, iFR was more likely than FFR to indicate hemodynamic significance < 5 days after STEMI whereas FFR was more likely than iFR to indicate hemodynamic significance after ≥ 5 days. The observations after ≥ 5 days probably resemble observations in stable conditions more closely, i.e., FFR is more often significant than iFR with similar outcomes of revascularisation guided by iFR and FFR [9, 10]. Within < 5 days after STEMI, both iFR and FFR may be affected, but in opposite directions, and the optimal method for nonculprit stenosis evaluation in this setting remains undetermined [4-8]. Also, the optimal time point for making this assessment remains to be established [2]. Different methods can be applied taking timing and potential bias of the used method in relation to timing into consideration [2]. In the acute or subacute setting, baseline flow may be increased and hyperemic flow may be decreased which may yield decreased iFR (overestimation of stenosis significance) and increased FFR (underestimation of stenosis significance) and these changes are expected to normalize over time although the time frame for this normalization is undetermined and may vary between patients [4-6]. In conclusion, in staged nonculprit stenosis evaluation after STEMI, iFR and FFR has an overall agreement that is comparable to that observed in stable patients. However, the time interval between STEMI and follow-up evaluation may impact agreement between iFR and FFR.

Limitations

The used cutoffs for iFR and FFR are based on previous studies and current clinical practice and derived from patients in stable condition. There was no clearly defined gold standard for ischemia detection. The cohort should ideally be a consecutive cohort, however, not all patients eligible patients were included during the study period. Without FFR in the acute setting, there is no information on the change in FFR. The observed iFR values were clustered around the cut-off for iFR. The distribution of iFR and FFR values may affect the agreement between the two methods. There was no data on microvascular obstruction or infarct size in these patients. Additional file 1. Individual values of follow-up iFR and FFR in patients with disagreement on nonculprit stenosis significance between iFR and FFR.
  10 in total

1.  Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.

Authors:  Matthias Götberg; Evald H Christiansen; Ingibjörg J Gudmundsdottir; Lennart Sandhall; Mikael Danielewicz; Lars Jakobsen; Sven-Erik Olsson; Patrik Öhagen; Hans Olsson; Elmir Omerovic; Fredrik Calais; Pontus Lindroos; Michael Maeng; Tim Tödt; Dimitrios Venetsanos; Stefan K James; Amra Kåregren; Margareta Nilsson; Jörg Carlsson; Dario Hauer; Jens Jensen; Ann-Charlotte Karlsson; Georgios Panayi; David Erlinge; Ole Fröbert
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

2.  Instantaneous wave-free ratio cutoff values for nonculprit stenosis classification in patients with ST-segment elevation myocardial infarction (an iSTEMI substudy).

Authors:  Troels Thim; Matthias Götberg; Ole Fröbert; Robin Nijveldt; Niels van Royen; Sergio Bravo Baptista; Sasha Koul; Thomas Kellerth; Hans Erik Bøtker; Christian Juhl Terkelsen; Evald Høj Christiansen; Lars Jakobsen; Steen Dalby Kristensen; Michael Maeng
Journal:  Coron Artery Dis       Date:  2020-08       Impact factor: 1.439

3.  Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: The WAVE study.

Authors:  Carmine Musto; Francesco De Felice; Stefano Rigattieri; Diana Chin; Andrea Marra; Marco Stefano Nazzaro; Alberta Cifarelli; Roberto Violini
Journal:  Am Heart J       Date:  2017-08-03       Impact factor: 4.749

Review 4.  Evaluation and Management of Nonculprit Lesions in STEMI.

Authors:  Troels Thim; Nina W van der Hoeven; Carmine Musto; Robin Nijveldt; Matthias Götberg; Thomas Engstrøm; Pieter C Smits; Keith G Oldroyd; Anthony H Gershlick; Javier Escaned; Sergio Bravo Baptista; Luis Raposo; Niels van Royen; Michael Maeng
Journal:  JACC Cardiovasc Interv       Date:  2020-05-25       Impact factor: 11.195

5.  Changes in Coronary Blood Flow After Acute Myocardial Infarction: Insights From a Patient Study and an Experimental Porcine Model.

Authors:  Guus A de Waard; Maurits R Hollander; Paul F A Teunissen; Matthijs F Jansen; Elise S Eerenberg; Aernout M Beek; Koen M Marques; Peter M van de Ven; Ingrid M Garrelds; A H Jan Danser; Dirk J Duncker; Niels van Royen
Journal:  JACC Cardiovasc Interv       Date:  2016-03-28       Impact factor: 11.195

6.  Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Nina W van der Hoeven; Gladys N Janssens; Guus A de Waard; Henk Everaars; Christopher J Broyd; Casper W H Beijnink; Peter M van de Ven; Robin Nijveldt; Christopher M Cook; Ricardo Petraco; Tim Ten Cate; Clemens von Birgelen; Javier Escaned; Justin E Davies; Maarten A H van Leeuwen; Niels van Royen
Journal:  JAMA Cardiol       Date:  2019-08-01       Impact factor: 14.676

7.  Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Troels Thim; Matthias Götberg; Ole Fröbert; Robin Nijveldt; Niels van Royen; Sergio Bravo Baptista; Sasha Koul; Thomas Kellerth; Hans Erik Bøtker; Christian Juhl Terkelsen; Evald Høj Christiansen; Lars Jakobsen; Steen Dalby Kristensen; Michael Maeng
Journal:  JACC Cardiovasc Interv       Date:  2017-11-29       Impact factor: 11.195

8.  Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry.

Authors:  Ricardo Petraco; Javier Escaned; Sayan Sen; Sukhjinder Nijjer; Kaleab N Asrress; Mauro Echavarria-Pinto; Tim Lockie; Muhammed Z Khawaja; Cecilia Cuevas; Nicolas Foin; Christopher Broyd; Rodney A Foale; Nearchos Hadjiloizou; Iqbal S Malik; Ghada W Mikhail; Amarjit Sethi; Raffi Kaprielian; Christopher S Baker; David Lefroy; Michael Bellamy; Mahmud Al-Bustami; Masood A Khan; Alun D Hughes; Darrel P Francis; Jamil Mayet; Carlo Di Mario; Simon Redwood; Justin E Davies
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534

9.  Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.

Authors:  Justin E Davies; Sayan Sen; Hakim-Moulay Dehbi; Rasha Al-Lamee; Ricardo Petraco; Sukhjinder S Nijjer; Ravinay Bhindi; Sam J Lehman; Darren Walters; James Sapontis; Luc Janssens; Christiaan J Vrints; Ahmed Khashaba; Mika Laine; Eric Van Belle; Florian Krackhardt; Waldemar Bojara; Olaf Going; Tobias Härle; Ciro Indolfi; Giampaolo Niccoli; Flavo Ribichini; Nobuhiro Tanaka; Hiroyoshi Yokoi; Hiroaki Takashima; Yuetsu Kikuta; Andrejs Erglis; Hugo Vinhas; Pedro Canas Silva; Sérgio B Baptista; Ali Alghamdi; Farrel Hellig; Bon-Kwon Koo; Chang-Wook Nam; Eun-Seok Shin; Joon-Hyung Doh; Salvatore Brugaletta; Eduardo Alegria-Barrero; Martijin Meuwissen; Jan J Piek; Niels van Royen; Murat Sezer; Carlo Di Mario; Robert T Gerber; Iqbal S Malik; Andrew S P Sharp; Suneel Talwar; Kare Tang; Habib Samady; John Altman; Arnold H Seto; Jasvindar Singh; Allen Jeremias; Hitoshi Matsuo; Rajesh K Kharbanda; Manesh R Patel; Patrick Serruys; Javier Escaned
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

10.  Staged re-evaluation of non-culprit lesions in ST segment elevation myocardial infarction: a retrospective study.

Authors:  Troels Thim; Gro Egholm; Kevin Kris Warnakula Olesen; Anne Kaltoft; Christian Juhl Terkelsen; Lars Romer Krusell; Steen Dalby Kristensen; Hans Erik Bøtker; Evald Høj Christiansen; Michael Maeng
Journal:  Open Heart       Date:  2016-06-24
  10 in total
  1 in total

Review 1.  Fractional Flow Reserve: Patient Selection and Perspectives.

Authors:  Joyce Peper; Leonie M Becker; Jan-Peter van Kuijk; Tim Leiner; Martin J Swaans
Journal:  Vasc Health Risk Manag       Date:  2021-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.